Christopher B. Cooper

Author

University of California, Los Angeles ORCID

Also Known As

, A Aalbers, Alejandro P. Comellas, Barjaktarevic, Igor Z, Bowler, Russell P., C Cooper, C. B. Cooper, C. Cooper, C. J. COOPER, C. J. Cooper

425

Publications

15.8K

Citations

H-Index

189

Concepts

All Affiliations

University of California, Los Angeles University of Utah University of North Carolina at Chapel Hill University of Iowa Johns Hopkins University

About

Christopher B. Cooper is an author at University of California, Los Angeles specializing in medicine, health sciences, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	21	28	1.7K
2	Engineering	5	5	133
3	Education	2	2	53
4	Business	1	1	33
5	Language Studies	1	1	25

Christopher B. Cooper

150

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen, JAMA	2004	2.3K
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu, JAMA	2003	1.7K
Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison Christopher B. Cooper, Reda A. El-Shiekh, David J. Cohen, American Heart Journal Percutaneous Coronary InterventionCardiac CatheterizationHealthcare ValueHealth EconomicsPatient Safety	1999	588
Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPD Richard Casaburi, David S. Kukafka, Christopher B. Cooper, CHEST Journal Exercise TolerancePhysical ActivityKinesiologyAdvanced Lung DiseaseExercise	2005	380
Airway Mucin Concentration as a Marker of Chronic Bronchitis Mehmet Kesımer, Amina A. Ford, Agathe Ceppe, New England Journal of Medicine	2017	359
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort Annette T. Hastie, Fernando J. Martínez, Jeffrey L. Curtis, The Lancet Respiratory Medicine EpidemiologyBlood Eosinophil ConcentrationsAdvanced Lung DiseaseMedicineClinical Epidemiology	2017	307
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort MeiLan K. Han, P. Miguel Quibrera, Elizabeth E. Carretta, The Lancet Respiratory Medicine	2017	304
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Giorgia Radicioni, Agathe Ceppe, Amina A. Ford, The Lancet Respiratory Medicine Spiromics CohortAdvanced Lung DiseaseMuc5b ConcentrationsPulmonary MedicineMedicine	2021	183
Ventilatory and Cardiovascular Responses to Exercise in Patients With Pectus Excavatum Moh H. Malek, Eric W. Fonkalsrud, Christopher B. Cooper CHEST Journal Physical ActivityKinesiologyExerciseExercise PhysiologyClinical Exercise Physiology	2003	173
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers Eleanor M. Dunican, Brett M. Elicker, Travis S. Henry, American Journal of Respiratory and Critical Care Medicine	2020	157

Page 1